News &amp; Updates

Olaparib safe, effective in ovarian cancer patients with BRCA mutation, HRD

Olaparib demonstrates clinical activity across patients with platinum-sensitive relapsed ovarian cancer and known BRCA mutation and homologous recombination deficiency (HRD), as shown in the phase II LIGHT study.

Olaparib safe, effective in ovarian cancer patients with BRCA mutation, HRD

15 Jul 2022

Genes for elevated blood pressure contribute to pre-eclampsia risk

Genetic predisposition to high blood pressure appears to heighten the risks of pre-eclampsia, recurrent pre-eclampsia, and pre-eclampsia with severe features, a study has found.

Genes for elevated blood pressure contribute to pre-eclampsia risk

Trastuzumab deruxtecan for HER2-low breast cancer: A treatment for a new population

Trastuzumab deruxtecan led to greater survival outcomes than chemotherapy treatment of physician’s choice (TPC)* in patients with HER2-low** advanced breast cancer, according to results of a phase III trial presented at ASCO 2022.

Trastuzumab deruxtecan for HER2-low breast cancer: A treatment for a new population

14 Jul 2022

Healthy sleep cuts frailty risk in older adults

Having good sleep health across multiple dimensions appears to reduce the risk of frailty among older adults, reports a recent Taiwan study.

Healthy sleep cuts frailty risk in older adults

Thermoelectric warming therapy beneficial in MGD-related dry eye disease

A device that applies consistent emissive heat to the meibomian glandular apparatus appears to produce significant improvements in the signs and symptoms of dry eye disease in patients with meibomian gland dysfunction (MGD), with the benefits sustained over 6 months following treatment initiation, as shown in a study.

Thermoelectric warming therapy beneficial in MGD-related dry eye disease

14 Jul 2022

Aspirin use lowers risk of liver cancer

A recent study has shown that use of aspirin can help reduce the risk of developing liver cancer.

Aspirin use lowers risk of liver cancer

PSA testing helps prevent prostate cancer deaths

A prostate specific antigen (PSA)-based screening is effective in significantly lowering the risk of death from prostate cancer (PC), reports a study. However, nonattendance, initiation after age 60 years, and discontinuation at age 70 years appear to increase such risk.

PSA testing helps prevent prostate cancer deaths

14 Jul 2022

Antiplatelet drugs up bleeding, decompensation events in cirrhosis patients

Use of antiplatelet (AP) medication appears to increase bleeding and decompensation events among privately insured patients with cirrhosis, a study has found. Use of nonsteroidal anti-inflammatory drug (NSAID) is also associated with significant early bleeding, but not decompensations. Anticoagulants (AC), on the other hand, are not associated with bleeding or decompensation outcomes.

Antiplatelet drugs up bleeding, decompensation events in cirrhosis patients

Disrupted gut fungi tied to colorectal cancer